NCT06624137View on ClinicalTrials.gov

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
OCDMajor Depressive Disorder (MDD)Alcohol Use Disorder (AUD)Healthy VolunteerMigrainePTSDPTSD - Post Traumatic Stress DisorderAddictionTobacco Use DisorderObsessive Compulsive Disorder (OCD)Opioid Use Disorder
Interventions
DRUG

Serotonergic Psychedelic

"Any serotonergic or classic psychedelic that exhibits mainly Serotonin 2A receptor (5-HT2AR) agonism and is judged to produce subjectively similar effects."

DRUG

Placebo

Matched Placebo

Trial Locations (2)

06517

RECRUITING

Connecticut Mental Health Center, Hamden

06516

RECRUITING

West Haven VA Medical Center, West Haven

All Listed Sponsors
collaborator

Burroughs Wellcome

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

lead

Yale University

OTHER